Showing articles whose micro-themes are very close to:
#Ebola therapeutic pipeline
- No closely related articles found yet.
- Safety, Tolerability, Pharmacokinetics, and Immunogenicity of mAb114 (pmc.ncbi.nlm.nih.gov) | 65d ago
- WHO Issues Updated Guideline on Therapeutics for Ebola Virus Disease (iris.who.int) | 62d ago
- FDA approves Ebanga (ansuvimab-zykl) for Zaire ebolavirus treatment (fda.gov) | 62d ago
- FDA-Approved Ebola Treatment Ebanga (fda.gov) | 65d ago
- Coalition for Epidemic Preparedness Innovations (CEPI) updates Ebola vaccine development progress (youtube.com) | 62d ago
- Gavi statement on the Ebola disease outbreak in Democratic Republic of the Congo and Uganda (gavi.org) | 66d ago
- WHO reports 906 suspected Ebola cases and 223 deaths from Bundibugyo strain in DRC (indiatoday.in) | 59d ago
- Ebola Vaccines Exist, But Not for Bundibugyo Strain in Current Uganda Outbreak (scientificamerican.com) | 65d ago
- Search Begins for Vaccine as Bundibugyo Ebola Deaths Rise (pharmaphorum.com) | 67d ago
- Factbox: Bundibugyo Ebola vaccines and treatments in development (devdiscourse.com) | 66d ago
- Ring Vaccination with rVSV-ZEBOV-GP Significantly Reduces Ebola Incidence (2minutemedicine.com) | 65d ago
- Bundibugyo Ebola virus outbreak in DRC and Uganda: no approved countermeasures (wellcome.org) | 59d ago
- WHO: Bundibugyo Ebola vaccine months away from human trials (nbcnews.com) | 68d ago
- Evidence to Recommendations for rVSVΔG-ZEBOV-GP Ebola Vaccine (cdc.gov) | 65d ago
- Ervebo vaccine: EMA EPAR summary for EU authorization (ema.europa.eu) | 62d ago
- WHO Advisory Group Recommends Maftivimab for Clinical Trials in Bundibugyo Ebola Outbreak (rttnews.com) | 59d ago
- Ervebo Vaccine: Efficacy and Deployment Against Zaire Ebolavirus (youtube.com) | 62d ago
- Brief review of Ebola virus disease and the One Health approach (pmc.ncbi.nlm.nih.gov) | 63d ago
- Bundibugyo Ebola Outbreak in Eastern DRC: No Approved Vaccines, Reliance on Experimental Treatments (devdiscourse.com) | 59d ago
- WHO Technical Advisory Group recommends BDBV-specific vaccines as preferred, considers Ervebo for post-exposure use in Bundibugyo outbreak (iris.who.int) | 63d ago
- FDA Expands ERVEBO Approval to Children Aged 12 Months and Older (merck.com) | 62d ago
- Analysis of Pandemic Emergency Facility Integration with IHR Compliance: Lessons from 2014 Ebola Outbreak (scholarship.law.vanderbilt.edu) | 63d ago
- ICTV Report: Orthoebolavirus Genus Taxonomy and Virology (ictv.global) | 26d ago
- WHO releases first comprehensive clinical guidelines for filovirus disease management (who.int) | 40d ago
- US aid cuts likely delayed detection of Ebola outbreak in DRC (npr.org) | 67d ago
- WHO emergency guidance on licensed Ebola vaccine use during Bundibugyo virus disease outbreaks (who.int) | 60d ago
- Development of Pandemic Vaccines: ERVEBO Case Study (pmc.ncbi.nlm.nih.gov) | 65d ago
- Report on Accelerating Ebola Vaccine Development: 2015 Recommendations from Wellcome Trust and CIDRAP (cidrap.umn.edu) | 4194d ago
- Review of Ebola Virus Outbreak Epidemiology and Treatment Advances (cureus.com) | 62d ago
- UK scientists develop novel Ebola vaccine; Serum Institute of India to mass-produce (youtube.com) | 61d ago
Showing page 1 of 1
(30 total results)
← Prev
Next →